Search

everythinglearnresearchcommunity

for

Search:↓

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

The document explains hair growth, hair loss types, and other hair-related terms.

The patient's hair loss is most likely due to diffuse alopecia areata.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

The guideline provides recommendations for managing alopecia areata effectively.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

A new method improves alopecia diagnosis using non-invasive steps.

Emotional symptoms from alopecia areata reduce work productivity and daily activity.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Exclamation mark hairs help distinguish syphilitic alopecia from alopecia areata.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Adipose tissue-derived exosomes may help regrow hair in alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.